
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Targeting PUS7 suppresses tRNA pseudouridylation and glioblastoma tumorigenesis
Qi Cui, Kailin Yin, Xiaoting Zhang, et al.
Nature Cancer (2021) Vol. 2, Iss. 9, pp. 932-949
Open Access | Times Cited: 107
Qi Cui, Kailin Yin, Xiaoting Zhang, et al.
Nature Cancer (2021) Vol. 2, Iss. 9, pp. 932-949
Open Access | Times Cited: 107
Showing 1-25 of 107 citing articles:
Quantitative sequencing using BID-seq uncovers abundant pseudouridines in mammalian mRNA at base resolution
Qing Dai, Lisheng Zhang, Hui‐Lung Sun, et al.
Nature Biotechnology (2022) Vol. 41, Iss. 3, pp. 344-354
Open Access | Times Cited: 157
Qing Dai, Lisheng Zhang, Hui‐Lung Sun, et al.
Nature Biotechnology (2022) Vol. 41, Iss. 3, pp. 344-354
Open Access | Times Cited: 157
Epigenetic regulation in the tumor microenvironment: molecular mechanisms and therapeutic targets
Jing Yang, Jin Xu, Wei Wang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 140
Jing Yang, Jin Xu, Wei Wang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 140
Regulation and functions of non-m6A mRNA modifications
Hanxiao Sun, Kai Li, Cong Liu, et al.
Nature Reviews Molecular Cell Biology (2023) Vol. 24, Iss. 10, pp. 714-731
Closed Access | Times Cited: 127
Hanxiao Sun, Kai Li, Cong Liu, et al.
Nature Reviews Molecular Cell Biology (2023) Vol. 24, Iss. 10, pp. 714-731
Closed Access | Times Cited: 127
Multi-omics approaches for biomarker discovery in early ovarian cancer diagnosis
Yinan Xiao, Meiyu Bi, Hongyan Guo, et al.
EBioMedicine (2022) Vol. 79, pp. 104001-104001
Open Access | Times Cited: 119
Yinan Xiao, Meiyu Bi, Hongyan Guo, et al.
EBioMedicine (2022) Vol. 79, pp. 104001-104001
Open Access | Times Cited: 119
Role of main RNA modifications in cancer: N6-methyladenosine, 5-methylcytosine, and pseudouridine
Chen Xue, Qingfei Chu, Qiuxian Zheng, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 118
Chen Xue, Qingfei Chu, Qiuxian Zheng, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 118
Decoding pseudouridine: an emerging target for therapeutic development
Jonas Cerneckis, Qi Cui, Chuan He, et al.
Trends in Pharmacological Sciences (2022) Vol. 43, Iss. 6, pp. 522-535
Open Access | Times Cited: 89
Jonas Cerneckis, Qi Cui, Chuan He, et al.
Trends in Pharmacological Sciences (2022) Vol. 43, Iss. 6, pp. 522-535
Open Access | Times Cited: 89
Quantitative profiling of pseudouridylation landscape in the human transcriptome
Meiling Zhang, Zhe Jiang, Yichen Ma, et al.
Nature Chemical Biology (2023) Vol. 19, Iss. 10, pp. 1185-1195
Open Access | Times Cited: 80
Meiling Zhang, Zhe Jiang, Yichen Ma, et al.
Nature Chemical Biology (2023) Vol. 19, Iss. 10, pp. 1185-1195
Open Access | Times Cited: 80
Genetic and epigenetic defects of the RNA modification machinery in cancer
Ines Oršolić, Arnaud Carrier, Manel Esteller
Trends in Genetics (2022) Vol. 39, Iss. 1, pp. 74-88
Open Access | Times Cited: 75
Ines Oršolić, Arnaud Carrier, Manel Esteller
Trends in Genetics (2022) Vol. 39, Iss. 1, pp. 74-88
Open Access | Times Cited: 75
RNA modifications in cancer
Qiling Tang, Lvyuan Li, Yumin Wang, et al.
British Journal of Cancer (2023) Vol. 129, Iss. 2, pp. 204-221
Open Access | Times Cited: 65
Qiling Tang, Lvyuan Li, Yumin Wang, et al.
British Journal of Cancer (2023) Vol. 129, Iss. 2, pp. 204-221
Open Access | Times Cited: 65
RNA modification: mechanisms and therapeutic targets
Lei Qiu, Jing Qian, Yanbo Li, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 64
Lei Qiu, Jing Qian, Yanbo Li, et al.
Molecular Biomedicine (2023) Vol. 4, Iss. 1
Open Access | Times Cited: 64
RNA Modification in the Immune System
Dali Han, Meng Xu
Annual Review of Immunology (2023) Vol. 41, Iss. 1, pp. 73-98
Open Access | Times Cited: 45
Dali Han, Meng Xu
Annual Review of Immunology (2023) Vol. 41, Iss. 1, pp. 73-98
Open Access | Times Cited: 45
METTL1 promotes tumorigenesis through tRNA-derived fragment biogenesis in prostate cancer
Raquel García-Vílchez, Ana M. Añazco-Guenkova, Sabine Dietmann, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 45
Raquel García-Vílchez, Ana M. Añazco-Guenkova, Sabine Dietmann, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 45
Deciphering the pseudouridine nucleobase modification in human diseases: From molecular mechanisms to clinical perspectives
Shiheng Jia, Xue Yu, Na Deng, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Shiheng Jia, Xue Yu, Na Deng, et al.
Clinical and Translational Medicine (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 2
CRISPR-free, programmable RNA pseudouridylation to suppress premature termination codons
Jinghui Song, Liting Dong, Hanxiao Sun, et al.
Molecular Cell (2022) Vol. 83, Iss. 1, pp. 139-155.e9
Open Access | Times Cited: 46
Jinghui Song, Liting Dong, Hanxiao Sun, et al.
Molecular Cell (2022) Vol. 83, Iss. 1, pp. 139-155.e9
Open Access | Times Cited: 46
tRNA modifications: insights into their role in human cancers
Ye Wang, En‐Wei Tao, Juan Tan, et al.
Trends in Cell Biology (2023) Vol. 33, Iss. 12, pp. 1035-1048
Closed Access | Times Cited: 29
Ye Wang, En‐Wei Tao, Juan Tan, et al.
Trends in Cell Biology (2023) Vol. 33, Iss. 12, pp. 1035-1048
Closed Access | Times Cited: 29
Advances in targeting RNA modifications for anticancer therapy
Monica Pomaville, Chuan He
Trends in cancer (2023) Vol. 9, Iss. 7, pp. 528-542
Open Access | Times Cited: 28
Monica Pomaville, Chuan He
Trends in cancer (2023) Vol. 9, Iss. 7, pp. 528-542
Open Access | Times Cited: 28
RNA modification in cardiovascular disease: implications for therapeutic interventions
Cong Wang, Xuyang Hou, Qing Guan, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 26
Cong Wang, Xuyang Hou, Qing Guan, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 26
tRNA Modifications and Modifying Enzymes in Disease, the Potential Therapeutic Targets
Weifang Cui, Deze Zhao, Junjie Jiang, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 4, pp. 1146-1162
Open Access | Times Cited: 24
Weifang Cui, Deze Zhao, Junjie Jiang, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 4, pp. 1146-1162
Open Access | Times Cited: 24
The rise of epitranscriptomics: recent developments and future directions
Jonas Cerneckis, Guo‐li Ming, Hongjun Song, et al.
Trends in Pharmacological Sciences (2023) Vol. 45, Iss. 1, pp. 24-38
Open Access | Times Cited: 23
Jonas Cerneckis, Guo‐li Ming, Hongjun Song, et al.
Trends in Pharmacological Sciences (2023) Vol. 45, Iss. 1, pp. 24-38
Open Access | Times Cited: 23
METTL5-mediated 18S rRNA m6A modification promotes oncogenic mRNA translation and intrahepatic cholangiocarcinoma progression
Zihao Dai, Wanjie Zhu, Yingdong Hou, et al.
Molecular Therapy (2023) Vol. 31, Iss. 11, pp. 3225-3242
Open Access | Times Cited: 22
Zihao Dai, Wanjie Zhu, Yingdong Hou, et al.
Molecular Therapy (2023) Vol. 31, Iss. 11, pp. 3225-3242
Open Access | Times Cited: 22
RNA modification-mediated mRNA translation regulation in liver cancer: mechanisms and clinical perspectives
Shuibin Lin, Ming Kuang
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 21, Iss. 4, pp. 267-281
Closed Access | Times Cited: 10
Shuibin Lin, Ming Kuang
Nature Reviews Gastroenterology & Hepatology (2024) Vol. 21, Iss. 4, pp. 267-281
Closed Access | Times Cited: 10
The impact of tRNA modifications on translation in cancer: identifying novel therapeutic avenues
Ana M. Añazco-Guenkova, Borja Miguel‐López, Óscar Monteagudo-García, et al.
NAR Cancer (2024) Vol. 6, Iss. 1
Open Access | Times Cited: 9
Ana M. Añazco-Guenkova, Borja Miguel‐López, Óscar Monteagudo-García, et al.
NAR Cancer (2024) Vol. 6, Iss. 1
Open Access | Times Cited: 9
PUS7‐dependent pseudouridylation of ALKBH3 mRNA inhibits gastric cancer progression
Yongxia Chang, Hao Jin, Yun Cui, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 8
Open Access | Times Cited: 9
Yongxia Chang, Hao Jin, Yun Cui, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 8
Open Access | Times Cited: 9
An old friend with a new face: tRNA-derived small RNAs with big regulatory potential in cancer biology
Arianna Di Fazio, Monika Gullerová
British Journal of Cancer (2023)
Open Access | Times Cited: 21
Arianna Di Fazio, Monika Gullerová
British Journal of Cancer (2023)
Open Access | Times Cited: 21
Why U matters: detection and functions of pseudouridine modifications in mRNAs
Rebecca Rodell, Nicolas Robalin, Nicole M. Martínez
Trends in Biochemical Sciences (2023) Vol. 49, Iss. 1, pp. 12-27
Closed Access | Times Cited: 19
Rebecca Rodell, Nicolas Robalin, Nicole M. Martínez
Trends in Biochemical Sciences (2023) Vol. 49, Iss. 1, pp. 12-27
Closed Access | Times Cited: 19